(Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -297.11%-115M | ---- | 210.51%58.35M | ---- | 18.88%-52.8M | ---- | -206.95%-65.09M | ---- | 87.65%60.86M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -1,900.00%-1.08M | ---- | 67.07%-54K | ---- | 37.40%-164K | ---- | 20.61%-262K | ---- | 50.00%-330K |
Dividend (income)- adjustment | ---- | -44.19%-124K | ---- | 11.34%-86K | ---- | 44.89%-97K | ---- | -1.73%-176K | ---- | -42.98%-173K |
Impairment and provisions: | --0 | 7,230.21%65.75M | --0 | -75.19%897K | --0 | --3.62M | --0 | --0 | --0 | 97.95%12.82M |
-Impairment of property, plant and equipment (reversal) | ---- | --57.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 797.44%8.05M | ---- | --897K | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | --3.62M | ---- | ---- | ---- | --12.82M |
Revaluation surplus: | --0 | 666.19%112.07M | --0 | -84.40%14.63M | --0 | 63.27%93.77M | --0 | 157.04%57.44M | --0 | -816.55%-100.69M |
-Fair value of investment properties (increase) | ---- | 668.74%109.5M | ---- | -84.91%14.24M | ---- | 67.12%94.42M | ---- | 155.65%56.5M | ---- | -888.08%-101.54M |
-Derivative financial instruments fair value (increase) | ---- | --2.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | 12.79%432K | ---- | 158.74%383K | ---- | -169.73%-652K | ---- | 10.91%935K | ---- | 218.73%843K |
Asset sale loss (gain): | --0 | --942K | --0 | --0 | --0 | --0 | --0 | ---1.1M | --0 | --0 |
-Loss (gain) on sale of property, machinery and equipment | ---- | --942K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.1M | ---- | ---- |
Depreciation and amortization: | --0 | -5.27%17.91M | --0 | 168.38%18.9M | --0 | -5.00%7.04M | --0 | -20.72%7.41M | --0 | -9.13%9.35M |
-Depreciation | ---- | -5.27%17.91M | ---- | 168.38%18.9M | ---- | -5.00%7.04M | ---- | -20.72%7.41M | ---- | -8.73%9.35M |
Financial expense | ---- | 173.02%35.88M | ---- | 1.99%13.14M | ---- | -41.30%12.89M | ---- | 35.54%21.95M | ---- | 208.42%16.2M |
Special items | ---- | ---11.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | --0 | -1.08%104.63M | --0 | 64.61%105.77M | --0 | 218.41%64.26M | --0 | 1,121.31%20.18M | --0 | -104.63%-1.98M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 371.71%478.35M | ---- | 59.52%-176.05M | ---- | -715.87%-434.9M | ---- | -84.94%70.62M | ---- | 230.23%468.89M |
Accounts receivable (increase)decrease | ---- | 652.93%331.62M | ---- | 32.47%-59.98M | ---- | 23.08%-88.81M | ---- | -235.79%-115.45M | ---- | 80.85%85.02M |
Accounts payable increase (decrease) | ---- | -2,039.79%-254.38M | ---- | -104.32%-11.89M | ---- | 24,086.04%274.88M | ---- | 96.71%-1.15M | ---- | -252.70%-34.83M |
prepayments (increase)decrease | ---- | 228.92%14.54M | ---- | 60.64%-11.28M | ---- | -262.41%-28.66M | ---- | -155.82%-7.91M | ---- | 215.36%14.17M |
Cash from business operations | --0 | 539.80%674.76M | --0 | 28.05%-153.42M | --0 | -532.51%-213.23M | --0 | -106.35%-33.71M | --0 | 304.46%531.28M |
Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -105.35%-35K | ---- | -90.82%654K |
Other taxs | ---- | ---276K | ---- | ---- | ---- | ---- | ---- | 89.76%-13K | ---- | ---127K |
Interest received - operating | ---- | 1,900.00%1.08M | ---- | -67.07%54K | ---- | -37.40%164K | ---- | -20.61%262K | ---- | -50.00%330K |
Interest paid - operating | ---- | -125.00%-9K | ---- | 73.33%-4K | ---- | 99.93%-15K | ---- | -35.54%-21.95M | ---- | -208.42%-16.2M |
Net cash from operations | -40.03%372.03M | 540.47%675.56M | 37.38%620.36M | 28.02%-153.37M | -2.43%451.57M | -284.28%-213.08M | 14.85%462.81M | -110.75%-55.45M | -31.59%402.96M | 300.52%515.94M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | 44.19%124K | ---- | -11.34%86K | ---- | -44.89%97K | ---- | 1.73%176K | ---- | 42.98%173K |
Restricted cash (increase) decrease | ---- | 880.34%1.15M | ---- | 103.90%117K | ---- | -131.95%-3M | ---- | --9.4M | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.02%-206K |
Sale of fixed assets | ---- | ---- | ---- | 39.17%977K | ---- | -97.68%702K | ---- | --30.2M | ---- | ---- |
Purchase of fixed assets | ---- | -37.12%-5.59M | ---- | -21.38%-4.08M | ---- | -236.47%-3.36M | ---- | 74.55%-998K | ---- | -300.20%-3.92M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.24M | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.1B |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.64M | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | --7.8M | ---- | ---- | ---- | ---- |
Net cash from investment operations | -397.41%-1.92M | -49.10%-4.32M | 50.13%-386K | -189.44%-2.9M | 84.08%-774K | -86.45%3.24M | -115.78%-4.86M | 102.16%23.89M | 127.68%30.83M | -3,010.61%-1.1B |
Net cash before financing | -40.30%370.11M | 529.54%671.24M | 37.53%619.97M | 25.53%-156.27M | -1.56%450.79M | -565.02%-209.84M | 5.57%457.95M | 94.63%-31.55M | -9.19%433.79M | -100.83%-588.02M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -8.29%1.97B | ---- | 8.15%2.15B | ---- | 68.10%1.99B | ---- | -26.02%1.18B | ---- | -5.96%1.6B |
Refund | ---- | -25.65%-2.45B | ---- | -2.61%-1.95B | ---- | -72.46%-1.9B | ---- | 13.98%-1.1B | ---- | 10.12%-1.28B |
Interest paid - financing | ---- | -173.03%-35.87M | ---- | -2.08%-13.14M | ---- | ---12.87M | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | 96.19%5.56M | ---- | -46.75%2.83M | ---- | -19.91%5.32M | ---- | -97.50%6.64M | ---- | --265.57M |
Net cash from financing operations | 10.10%-541.27M | -364.67%-506.49M | -41.33%-602.09M | 133.93%191.36M | 8.41%-426.02M | -7.36%81.8M | -5.83%-465.15M | -84.88%88.3M | 15.69%-439.54M | 111.88%584.09M |
Effect of rate | 40.42%-342K | -72.82%-1.15M | -298.62%-574K | 73.74%-666K | 35.68%289K | 62.18%-2.54M | -20.22%213K | -63.18%-6.71M | 10.79%267K | -471.49%-4.11M |
Net Cash | -1,057.19%-171.16M | 369.43%164.75M | -27.82%17.88M | 127.41%35.1M | 443.89%24.77M | -325.62%-128.04M | -25.13%-7.2M | 1,545.07%56.75M | 86.82%-5.76M | 77.07%-3.93M |
Begining period cash | 162.65%264.17M | 52.05%100.58M | 52.05%100.58M | -66.37%66.15M | -66.37%66.15M | 34.12%196.72M | 34.12%196.72M | -5.19%146.68M | -5.19%146.68M | -10.34%154.72M |
Cash at the end | -21.39%92.68M | 162.65%264.17M | 29.24%117.89M | 52.05%100.58M | -51.93%91.21M | -66.37%66.15M | 34.38%189.73M | 34.12%196.72M | 26.89%141.19M | -5.19%146.68M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data